Fenoflick 145 Tablet contains Fenofibrate 145mg, a lipid-lowering agent used for management of high cholesterol, elevated triglycerides, and mixed dyslipidemia. It helps reduce cardiovascular risk in patients with lipid disorders.
Fenofibrate works by activating peroxisome proliferator-activated receptor alpha (PPARα), which increases lipid metabolism, reduces triglycerides, and improves HDL cholesterol levels. This mechanism supports overall cardiovascular health.
This tablet is commonly prescribed for patients with hyperlipidemia, mixed dyslipidemia, or metabolic syndrome, providing effective lipid control and long-term prevention of cardiovascular events.
Fenoflick 145 Tablet is valued for its efficacy, clinical reliability, and high prescription demand, making it a trusted option in cardiac care. Its role in managing cholesterol and triglycerides supports heart health and enhances patient adherence in chronic therapy regimens.
Common side effects may include gastrointestinal discomfort, nausea, abdominal pain, or mild headache. Rare but serious side effects include liver enzyme elevations, muscle pain or weakness (myopathy), and allergic reactions. Patients should report persistent or severe symptoms to their healthcare provider.
Fenoflick 145 Tablet is indicated for the treatment of hypertriglyceridemia, mixed dyslipidemia, and hypercholesterolemia, particularly in patients at risk of cardiovascular disease. It is used as part of a comprehensive treatment plan including diet, exercise, and lifestyle modifications.
Fenoflick 145 Tablet should be taken exactly as prescribed, preferably with meals. Liver function tests may be required periodically during treatment. Patients should avoid combining with other lipid-lowering medications without medical advice and maintain regular monitoring of kidney and liver function.
Store Fenoflick 145 Tablet in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and do not use after the expiry date mentioned on the packaging.